Funding for this research was provided by:
National Natural Science Foundation of China (81603460)
Postdoctoral Science Foundation of China (2015 M581533)
Received: 9 August 2019
Accepted: 26 January 2020
First Online: 17 March 2020
Ethics approval and consent to participate
: This trial complies with the principles of Declaration of Helsinki and the regulations of quality management of clinical trials in China. The research activities in this trial have been approved by the Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine. The committee’s reference number is BF2018–182-01 (Table InternalRef removed). All study participants will sign written ICFs before participating in the trial.
: Not applicable.
: The authors declare that they have no competing interests.